Caplacizumab as a single agent without plasma exchange in relapsed and refractory thrombotic thrombocytopenic purpura: A systematic review.
Year: 2025
Type: conference-abstract
Source: Blood
Institution: University of Oklahoma Health Sciences Center
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4417019110
